Skip to main content
. 2014 Dec 5;6(4):5133. doi: 10.4081/ni.2014.5133

Table 4.

Adverse events reported in the studied population.

Botx-A (n=20) Placebo (n=18)
Adverse events (total) 9 (45.0%) 7 (38.8%)
Pain in injected points 6 (30.0%) 2 (11.1%)
Burning sensation in injected points 4 (20.0%) 2 (11.1%)
Headache after injection 2 (10.0%) 1 (5.5%)